TARGET: Acute Lymphoblastic Leukemia (ALL) Phase I Pilot

There are 189 fully characterized patient cases that make up the pilot phase (Phase I) of the TARGET ALL dataset, each with gene expression, tumor and paired normal copy number analyses, and at least one type of sequencing (Sanger and/or next-generation) data available. There are 230 cases with partial molecular characterization and/or sequencing data available, to include whole genome sequencing, mRNA-seq and/or kinome sequencing. Please visit the TARGET website, https://www.cancer.gov/ccg/research/genome-sequencing/target, for additional information on this and other TARGET genomics projects. Please see the TARGET Publication Guidelines for updated details on the sharing of any TARGET substudy data.